Show latest about:
Israeli stocks on Wall St
Israeli stocks in Europe
Mergers & acquisitions
Politics, foreign affairs
Start-ups & VC
Israeli stocks in NY
Israel in depth
Cardiac monitoring co Vectorious raises $5m
Vectorious Medical Technologies is developing a novel cardiac monitoring system for congestive heart failure patients.
25 Feb 15 15:37
Teva reports positive migraine drug Phase IIb results
Both high and low dose TEV-48125 demonstrated significant reduction in headache hours and headache days in patients.
24 Feb 15 19:14
Israeli, UK researchers awarded £3m grants
The grants are part of a £10 million program for cooperation between the UK and Israel on regenerative medicine.
22 Feb 15 17:18
Valeant buying Salix in $10b deal
Valeant Pharmaceuticals has been mentioned as a possible buyer of Israel's Teva.
22 Feb 15 10:00
Check-Cap raises $24m, including Nasdaq IPO
19 Feb 15 17:31
Teva launches injectable generic Lovenox and Zyvox
18 Feb 15 11:24
Pocared Diagnostics raises $15m
17 Feb 15 16:47
Teva agrees licensing for Eagle leukemia drug
17 Feb 15 15:09
Epoch invests NIS 21.2m in IceCure Medical
17 Feb 15 14:25
Clal Biotech and Hyperion settle on Andromeda
17 Feb 15 12:57
Fosun Pharma eyes Lumenis
17 Feb 15 11:09
Rainbow Medical raises $25m from Chinese investors
16 Feb 15 14:45
Novartis seeks new Israeli technologies
15 Feb 15 15:43
What Cyprus offers Israel's medical tourism industry
Local conditions combined with recent EU legislation make Cyprus an attractive target for healthcare investment.
24 Feb 15 11:16
Myndlift: An Israeli app being developed to treat ADHD
Two entrepreneurs from Baqa al-Gharbiya are building an app-based neuro-feedback system for drug-free ADHD treatment.
4 Feb 15 21:57
Jeremy Levin: Teva is continuing my focus
The former Teva CEO tells "Globes" about his new jobs with Biocon and Ovid.
29 Jan 15 16:50
1,000 red grapes in a single teaspoon
22 Jan 15 10:37
Israeli biomed cos shun TASE for Nasdaq
4 Jan 15 11:29
Good-bye chemotherapy, hello immunotherapy
27 Nov 14 11:36
Cancer treatment developer Efranat raises $4.5m
18 Nov 14 16:13